Return to CBI Antibody Core Home Page
  Return to biothreat/emerging pathogens list
    Return to malaria parasite (malaria (P. falciparum)) ( Plasmodium falciparum ) list


malaria parasite (malaria (P. falciparum)) ( Plasmodium falciparum )
s230


Antibody Name/Abbreviation: s230
CBI Antibody Core Code: A0472

"Lot" Number: 1 Position: 100(681-780)
% Identical Homology of Target to Mouse Protein: 33% (XP_358252.2| similar to CHCHD4 protein)
Molecular Weight of fusion protein: N.A. KDa

Target sequence used to make this antibody:
NNFKEGVIEFTLPPVVHKATVFYFICDNSKTEDDNKKGNR
GIVEVYVEPYGNKINGCAFLDEDEEEEKYGNQIEEDEHNE
KIKMKTFFTQNIYKKNNIYP






Sequence Name: s230
Full name:
UniGene Number: N.A.
Accession Number: PFB0405w
Source organism: malaria parasite (malaria (P. falciparum)) ( Plasmodium falciparum )
Full length size (aa): 3135
NCBI information page: click here

Full length sequence:
MKKIITLKNLFLIILVYIFSEKKDLRCNVIKGNNIKDDEDKRFHLFYYSH
NLFKTPETKEKKNKKECFYKNGGIYNLSKEIRMRKDTSVKIKQRTCPFHK
EGSSFEMGSKNITCFYPIVGKKERKTLDTIIIKKNVTNDHVVSSDMHSNV
QEKNMILIRNIDKENKNDIQNVEEKIQRDTYENKDYESDDTLIEWFDDNT
NEENFLLTFLKRCLMKIFSSPKRKKTVVQKKHKSNFFINSSLKYIYMYLT
PSDSFNLVRRNRNLDEEDMSPRDNFVIDDEEEEEEEEEEEEEEEEEEEEE
EEEEYDDYVYEESGDETEEQLQEEHQEEVGAESSEESFNDEDEDSVEARD
GDMIRVDEYYEDQDGDTYDSTIKNEDVDEEVGEEVGEEVGEEVGEEVGEE
VGEEVGEEVGEEVGEEEGEEVGEGVGEEVGEEEGEEVGEEEGEYVDEKER
QGEIYPFGDEEEKDEGGESFTYEKSEVDKTDLFKFIEGGEGDDVYKVDGS
KVLLDDDTISRVSKKHTARDGEYGEYGEAVEDGENVIKIIRSVLQSGALP
SVGVDELDKIDLSYETTESGDTAVSEDSYDKYASNNTNKEYVCDFTDQLK
PTESGPKVKKCEVKVNEPLIKVKIICPLKGSVEKLYDNIEYVPKKSPYVV
LTKEETKLKEKLLSKLIYGLLISPTVNEKENNFKEGVIEFTLPPVVHKAT
VFYFICDNSKTEDDNKKGNRGIVEVYVEPYGNKINGCAFLDEDEEEEKYG
NQIEEDEHNEKIKMKTFFTQNIYKKNNIYPCYMKLYSGDIGGILFPKNIK
STTCFEEMIPYNKEIKWNKENKSLGNLVNNSVVYNKEMNAKYFNVQYVHI
PTSYKDTLNLFCSIILKEEESNLISTSYLVYVSINEELNFSLFDFYESFV
PIKKTIQVAQKNVNNKEHDYTCDFTDKLDKTVPSTANGKKLFICRKHLKE
FDTFTLKCNVNKTQYPNIEIFPKTLKDKKEVLKLDLDIQYQMFSKFFKFN
TQNAKYLNLYPYYLIFPFNHIGKKELKNNPTYKNHKDVKYFEQSSVLSPL
SSADSLGKLLNFLDTQETVCLTEKIRYLNLSINELGSDNNTFSVTFQVPP
YIDIKEPFYFMFGCNNNKGEGNIGIVELLISKQEEKIKGCNFHESKLDYF
NENISSDTHECTLHAYENDIIGFNCLETTHPNEVEVEVEDAEIYLQPENC
FNNVYKGLNSVDITTILKNAQTYNINNKKTPTFLKIPPYNLLEDVEISCQ
CTIKQVVKKIKVIITKNDTVLLKREVQSESTLDDKIYKCEHENFINPRVN
KTFDENVEYTCNIKIENFFNYIQIFCPAKDLGIYKNIQMYYDIVKPTRVP
QFKKFNNEELHKLIPNSEMLHKTKEMLILYNEEKVDLLHFYVFLPIYIKD
IYEFNIVCDNSKTMWKNQLGGKVIYHITVSKREQKVKGCSFDNEHAHMFS
YNKTNVKNCIIDAKPKDLIGFVCPSGTLKLTNCFKDAIVHTNLTNINGIL
YLKNNLANFTYKHQFNYMEIPALMDNDISFKCICVDLKKKKYNVKSPLGP
KVLRALYKKLNIKFDNYVTGTDQNKYLMTYMDLHLSHKRNYLKELFHDLG
KKKPADTDANPESIIESLSINESNESGPFPTGDVDAEHLILEGYDTWESL
YDEQLEEVIYNDIESLELKDIEQYVLQVNLKAPKLMMSAQIHNNRHVCDF
SKNNLIVPESLKKKEELGGNPVNIHCYALLKPLDTLYVKCPTSKDNYEAA
KVNISENDNEYELQVISLIEKRFHNFETLESKKPGNGDVVVHNGVVDTGP
VLDNSTFEKYFKNIKIKPDKFFEKVINEYDDTEEEKDLESILPGAIVSPM
KVLKKKDPFTSYAAFVVPPIVPKDLHFKVECNNTEYKDENQYISGYNGII
HIDISNSNRKINGCDFSTNNSSILTSSVKLVNGETKNCEININNNEVFGI
ICDNETNLDPEKCFHEIYSKDNKTVKKFREVIPNIDIFSLHNSNKKKVAY
AKVPLDYINKLLFSCSCKTSHTNTIGTMKVTLNKDEKEEEDFKTAQGIKH
NNVHLCNFFDNPELTFDNNKIVLCKIDAELFSEVIIQLPIFGTKNVEEGV
QNEEYKKFSLKPSLVFDDNNNDIKVIGKEKNEVSISLALKGVYGNRIFTF
DKNGKKGEGISFFIPPIKQDTDLKFIINETIDNSNIKQRGLIYIFVRKNV
SENSFKLCDFTTGSTSLMELNSQVKEKKCTVKIKKGDIFGLKCPKGFAIF
PQACFSNVLLEYYKSDYEDSEHINYYIHKDKKYNLKPKDVIELMDENFRE
LQNIQQYTGISNITDVLHFKNFNLGNLPLNFKNHYSTAYAKVPDTFNSII
NFSCNCYNPEKHVYGTMQVESDNRNFDNIKKNENVIKNFLLPNIEKYALL
LDDEERQKKIKQQQEEEQQEQILKDQDDRLSRHDDYNKNHTYILYDSNEH
ICDYEKNESLISTLPNDTKKIQKSICKINAKALDVVTIKCPHTKNFTPKD
YFPNSSLITNDKKIVITFDKKNFVTYIDPTKKTFSLKDIYIQSFYGVSLD
HLNQIKKIHEEWDDVHLFYPPHNVLHNVVLNNHIVNLSSALEGVLFMKSK
VTGDETATKKNTTLPTDGVSSILIPPYVKEDITFHLFCGKSTTKKPNKKN
TSLALIHIHISSNRNIIHGCDFLYLENQTNDAISNNNNNSYSIFTHNKNT
ENNLICDISLIPKTVIGIKCPNKKLNPQTCFDEVYYVKQEDVPSKTITAD
KYNTFSKDKIGNILKNAISINNPDEKDNTYTYLILPEKFEEELIDTKKVL
ACTCDNKYIIHMKIEKSTMDKIKIDEKKTIGKDICKYDVTTKVATCEIID
TIDSSVLKEHHTVHYSITLSRWDKLIIKYPTNEKTHFENFFVNPFNLKDK
VLYNYNKPINIEHILPGAITTDIYDTRTKIKQYILRIPPYVHKDIHFSLE
FNNSLSLTKQNQNIIYGNVAKIFIHINQGYKEIHGCDFTGKYSHLFTYSK
KPLPNDDDICNVTIGNNTFSGFACLSHFELKPNNCFSSVYDYNEANKVKK
LFDLSTKVELDHIKQNTSGYTLSYIIFNKESTKLKFSCTCSSNYSNYTIR
ITFDPNYIIPEPQSRAIIKYVDLQDKNFAKYLRKL





Questions? Click here for answers.


© Monday, February 16, 2009 by the CBI Antibody Core and the Center for Biomedical Inventions, University of Texas Southwestern Medical School.